Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 30 | 2023 | 8791 | 3.310 |
Why?
|
Radiosurgery | 11 | 2023 | 1305 | 2.490 |
Why?
|
Meningeal Neoplasms | 6 | 2023 | 1234 | 2.040 |
Why?
|
Cranial Irradiation | 5 | 2023 | 402 | 1.830 |
Why?
|
Radiotherapy | 4 | 2021 | 1526 | 1.080 |
Why?
|
Meningioma | 3 | 2020 | 1202 | 0.840 |
Why?
|
DNA Modification Methylases | 1 | 2020 | 206 | 0.720 |
Why?
|
Memantine | 1 | 2020 | 100 | 0.700 |
Why?
|
DNA Repair Enzymes | 1 | 2020 | 348 | 0.660 |
Why?
|
Prolactinoma | 1 | 2018 | 113 | 0.630 |
Why?
|
Neurosurgical Procedures | 6 | 2019 | 1994 | 0.620 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2020 | 449 | 0.620 |
Why?
|
Prescriptions | 1 | 2020 | 383 | 0.610 |
Why?
|
Prostatectomy | 3 | 2020 | 1858 | 0.590 |
Why?
|
Hypopituitarism | 1 | 2019 | 254 | 0.580 |
Why?
|
Triiodothyronine | 1 | 2018 | 491 | 0.560 |
Why?
|
Waiting Lists | 2 | 2019 | 692 | 0.550 |
Why?
|
Hydrocephalus | 2 | 2020 | 744 | 0.520 |
Why?
|
Melanoma | 3 | 2022 | 5446 | 0.520 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1045 | 0.490 |
Why?
|
Fertility | 1 | 2018 | 775 | 0.470 |
Why?
|
Endarterectomy, Carotid | 1 | 2018 | 543 | 0.450 |
Why?
|
Pituitary Neoplasms | 2 | 2018 | 1334 | 0.450 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2023 | 5154 | 0.430 |
Why?
|
Lung Neoplasms | 7 | 2023 | 12985 | 0.430 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2901 | 0.410 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 2910 | 0.400 |
Why?
|
Head | 1 | 2016 | 876 | 0.380 |
Why?
|
Carotid Stenosis | 1 | 2018 | 851 | 0.380 |
Why?
|
Prognosis | 13 | 2023 | 28901 | 0.380 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2845 | 0.370 |
Why?
|
Glioblastoma | 2 | 2022 | 3431 | 0.340 |
Why?
|
Retrospective Studies | 24 | 2023 | 76631 | 0.330 |
Why?
|
SEER Program | 4 | 2021 | 1506 | 0.330 |
Why?
|
Neuroma, Acoustic | 2 | 2022 | 449 | 0.320 |
Why?
|
Humans | 66 | 2023 | 739398 | 0.300 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3382 | 0.300 |
Why?
|
DNA Methylation | 1 | 2020 | 4269 | 0.280 |
Why?
|
Organ Transplantation | 1 | 2016 | 1131 | 0.280 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2020 | 1771 | 0.280 |
Why?
|
Cognition Disorders | 1 | 2020 | 4026 | 0.270 |
Why?
|
Watchful Waiting | 2 | 2020 | 489 | 0.260 |
Why?
|
Glioma | 4 | 2022 | 3378 | 0.260 |
Why?
|
Prostatic Neoplasms | 4 | 2020 | 10999 | 0.260 |
Why?
|
Pain | 1 | 2019 | 4923 | 0.240 |
Why?
|
Breast Neoplasms | 5 | 2023 | 20676 | 0.240 |
Why?
|
Craniotomy | 2 | 2020 | 728 | 0.240 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5632 | 0.220 |
Why?
|
Female | 28 | 2023 | 378853 | 0.220 |
Why?
|
Clinical Competence | 1 | 2018 | 4671 | 0.210 |
Why?
|
Spinal Fusion | 2 | 2023 | 1236 | 0.210 |
Why?
|
Radiation Injuries | 2 | 2019 | 1161 | 0.200 |
Why?
|
Treatment Outcome | 16 | 2023 | 62693 | 0.200 |
Why?
|
Quality of Life | 3 | 2021 | 12640 | 0.190 |
Why?
|
Aged | 17 | 2021 | 162698 | 0.190 |
Why?
|
Male | 25 | 2022 | 349022 | 0.190 |
Why?
|
Tinnitus | 1 | 2022 | 195 | 0.180 |
Why?
|
Cell Cycle Proteins | 2 | 2023 | 3433 | 0.180 |
Why?
|
Pain Measurement | 2 | 2019 | 3419 | 0.180 |
Why?
|
Third Ventricle | 1 | 2020 | 76 | 0.180 |
Why?
|
Cohort Studies | 10 | 2022 | 40389 | 0.170 |
Why?
|
Galactorrhea | 1 | 2018 | 24 | 0.170 |
Why?
|
Spinal Curvatures | 1 | 2019 | 66 | 0.170 |
Why?
|
Neoplasm Seeding | 1 | 2019 | 87 | 0.170 |
Why?
|
Survival Rate | 4 | 2020 | 12761 | 0.170 |
Why?
|
Ventriculostomy | 1 | 2020 | 136 | 0.170 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2020 | 194 | 0.170 |
Why?
|
Thyroid Function Tests | 1 | 2019 | 284 | 0.160 |
Why?
|
Tranexamic Acid | 1 | 2019 | 144 | 0.150 |
Why?
|
Central Nervous System Cysts | 1 | 2018 | 58 | 0.150 |
Why?
|
Follow-Up Studies | 7 | 2021 | 38942 | 0.150 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2019 | 190 | 0.150 |
Why?
|
Brain Abscess | 1 | 2018 | 118 | 0.150 |
Why?
|
Hospital Bed Capacity | 1 | 2018 | 214 | 0.150 |
Why?
|
Antifibrinolytic Agents | 1 | 2019 | 251 | 0.150 |
Why?
|
Middle Aged | 18 | 2020 | 212863 | 0.150 |
Why?
|
Incidence | 4 | 2023 | 20913 | 0.140 |
Why?
|
Prolactin | 1 | 2018 | 668 | 0.140 |
Why?
|
Steroids | 1 | 2021 | 925 | 0.140 |
Why?
|
Pituitary Gland | 1 | 2019 | 667 | 0.140 |
Why?
|
Laser Therapy | 1 | 2022 | 1065 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 603 | 0.130 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 231 | 0.130 |
Why?
|
Stroke | 1 | 2018 | 9898 | 0.130 |
Why?
|
Salvage Therapy | 2 | 2019 | 1269 | 0.130 |
Why?
|
Spinal Diseases | 1 | 2020 | 540 | 0.130 |
Why?
|
Behavior | 1 | 2018 | 561 | 0.130 |
Why?
|
Hearing Loss | 1 | 2022 | 759 | 0.130 |
Why?
|
Mortality | 4 | 2019 | 2851 | 0.130 |
Why?
|
Amenorrhea | 1 | 2018 | 485 | 0.130 |
Why?
|
Adult | 15 | 2022 | 213394 | 0.120 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2017 | 341 | 0.120 |
Why?
|
Personality | 1 | 2018 | 547 | 0.120 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2018 | 628 | 0.120 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 3650 | 0.120 |
Why?
|
Monitoring, Intraoperative | 1 | 2021 | 954 | 0.120 |
Why?
|
United States | 5 | 2022 | 69573 | 0.120 |
Why?
|
Travel | 1 | 2019 | 787 | 0.120 |
Why?
|
Treatment Failure | 1 | 2019 | 2614 | 0.110 |
Why?
|
Scoliosis | 1 | 2020 | 720 | 0.110 |
Why?
|
Attitude | 1 | 2018 | 770 | 0.110 |
Why?
|
Medicare | 2 | 2021 | 6497 | 0.110 |
Why?
|
Tumor Burden | 1 | 2018 | 1904 | 0.110 |
Why?
|
Surgery, Computer-Assisted | 1 | 2021 | 1008 | 0.110 |
Why?
|
Combined Modality Therapy | 3 | 2020 | 8605 | 0.110 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 2872 | 0.100 |
Why?
|
Antibiotic Prophylaxis | 1 | 2017 | 631 | 0.100 |
Why?
|
Medical Informatics | 1 | 2019 | 740 | 0.100 |
Why?
|
Spine | 1 | 2019 | 1144 | 0.100 |
Why?
|
Syndrome | 1 | 2018 | 3241 | 0.100 |
Why?
|
Brachytherapy | 1 | 2019 | 1247 | 0.100 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2020 | 1625 | 0.100 |
Why?
|
Risk Assessment | 4 | 2020 | 23294 | 0.100 |
Why?
|
Natural Language Processing | 1 | 2019 | 1024 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 1 | 2023 | 4555 | 0.100 |
Why?
|
Dexamethasone | 1 | 2018 | 1948 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2018 | 1824 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1534 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2020 | 2583 | 0.090 |
Why?
|
Vision Disorders | 1 | 2017 | 1058 | 0.090 |
Why?
|
Prostate-Specific Antigen | 1 | 2020 | 2441 | 0.090 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57650 | 0.090 |
Why?
|
Headache | 1 | 2018 | 1199 | 0.090 |
Why?
|
Tissue and Organ Procurement | 1 | 2018 | 891 | 0.090 |
Why?
|
Data Collection | 1 | 2019 | 3341 | 0.090 |
Why?
|
DNA | 1 | 2023 | 7275 | 0.090 |
Why?
|
Lung Transplantation | 1 | 2018 | 1154 | 0.090 |
Why?
|
Databases, Factual | 2 | 2022 | 7690 | 0.080 |
Why?
|
Necrosis | 2 | 2023 | 1643 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2021 | 3606 | 0.080 |
Why?
|
Activities of Daily Living | 1 | 2018 | 2410 | 0.080 |
Why?
|
History, 20th Century | 1 | 2016 | 2742 | 0.080 |
Why?
|
Prevalence | 3 | 2020 | 15153 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1777 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2948 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 4 | 2020 | 6516 | 0.080 |
Why?
|
Anxiety | 2 | 2019 | 4253 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2017 | 1530 | 0.080 |
Why?
|
Genomics | 1 | 2023 | 5652 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3614 | 0.080 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7726 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2167 | 0.070 |
Why?
|
Mutation | 2 | 2023 | 29658 | 0.070 |
Why?
|
Adolescent | 5 | 2022 | 85405 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1673 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2521 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2782 | 0.070 |
Why?
|
Disease Progression | 2 | 2019 | 13237 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2059 | 0.070 |
Why?
|
Multivariate Analysis | 4 | 2020 | 12237 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3138 | 0.060 |
Why?
|
Radiology | 1 | 2019 | 2080 | 0.060 |
Why?
|
Prospective Studies | 7 | 2023 | 53037 | 0.060 |
Why?
|
Time Factors | 4 | 2019 | 40050 | 0.060 |
Why?
|
Child, Preschool | 3 | 2022 | 40802 | 0.060 |
Why?
|
Europe | 2 | 2021 | 3331 | 0.060 |
Why?
|
Infant | 2 | 2022 | 34923 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7136 | 0.050 |
Why?
|
Lumbosacral Region | 1 | 2023 | 309 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 2913 | 0.050 |
Why?
|
Survival Analysis | 3 | 2020 | 10247 | 0.050 |
Why?
|
Child | 4 | 2022 | 77033 | 0.050 |
Why?
|
Radiation Dosage | 2 | 2021 | 1920 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6318 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5272 | 0.050 |
Why?
|
Vertigo | 1 | 2022 | 200 | 0.050 |
Why?
|
Hemangioendothelioma | 1 | 2021 | 121 | 0.050 |
Why?
|
Pain, Postoperative | 2 | 2020 | 1638 | 0.050 |
Why?
|
Facial Nerve | 1 | 2022 | 259 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2020 | 15194 | 0.050 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12328 | 0.040 |
Why?
|
Dizziness | 1 | 2022 | 251 | 0.040 |
Why?
|
Receptor, erbB-2 | 2 | 2020 | 2370 | 0.040 |
Why?
|
Lymphatic Abnormalities | 1 | 2021 | 133 | 0.040 |
Why?
|
Lordosis | 1 | 2020 | 82 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11410 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 35326 | 0.040 |
Why?
|
Neuroendoscopy | 1 | 2020 | 105 | 0.040 |
Why?
|
Depression | 1 | 2018 | 7689 | 0.040 |
Why?
|
Lasers | 1 | 2022 | 945 | 0.040 |
Why?
|
Brain | 2 | 2023 | 26345 | 0.040 |
Why?
|
Risk Factors | 3 | 2020 | 71974 | 0.040 |
Why?
|
Sarcoma, Kaposi | 1 | 2021 | 365 | 0.040 |
Why?
|
Privacy | 1 | 2019 | 236 | 0.040 |
Why?
|
Pregnancy | 1 | 2018 | 29002 | 0.040 |
Why?
|
Microsurgery | 1 | 2022 | 793 | 0.040 |
Why?
|
Ownership | 1 | 2019 | 331 | 0.040 |
Why?
|
Research Report | 1 | 2019 | 351 | 0.030 |
Why?
|
Patient Selection | 2 | 2018 | 4211 | 0.030 |
Why?
|
Preoperative Period | 1 | 2018 | 546 | 0.030 |
Why?
|
Vascular Malformations | 1 | 2021 | 442 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2019 | 658 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2500 | 0.030 |
Why?
|
Postoperative Period | 1 | 2020 | 1835 | 0.030 |
Why?
|
Penicillins | 1 | 2017 | 384 | 0.030 |
Why?
|
Logistic Models | 2 | 2020 | 13402 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2019 | 10961 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2019 | 1094 | 0.030 |
Why?
|
Perioperative Care | 1 | 2021 | 995 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2023 | 1843 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1763 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9812 | 0.030 |
Why?
|
Oncolytic Virotherapy | 1 | 2019 | 489 | 0.030 |
Why?
|
Physical Fitness | 1 | 2018 | 733 | 0.030 |
Why?
|
Informed Consent | 1 | 2019 | 988 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2020 | 1383 | 0.030 |
Why?
|
Neurosurgery | 1 | 2018 | 643 | 0.030 |
Why?
|
ROC Curve | 1 | 2019 | 3526 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2019 | 2183 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2217 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5058 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2021 | 3097 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3564 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2448 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2727 | 0.020 |
Why?
|
Animals | 2 | 2019 | 168368 | 0.020 |
Why?
|
Hippocampus | 1 | 2020 | 3657 | 0.020 |
Why?
|
Graft Survival | 1 | 2018 | 3723 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6722 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9684 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6295 | 0.020 |
Why?
|
Heart | 1 | 2019 | 4466 | 0.020 |
Why?
|
Graft Rejection | 1 | 2018 | 4379 | 0.020 |
Why?
|
Anticoagulants | 1 | 2019 | 4582 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 56255 | 0.010 |
Why?
|
Immunotherapy | 1 | 2019 | 4391 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4216 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5502 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4426 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18349 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 25470 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9122 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19811 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 13872 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13635 | 0.010 |
Why?
|
Concepts
(235)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(82)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_